Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1983 1
1984 1
1986 2
1988 1
1993 1
1994 2
1995 3
1996 2
1997 1
1998 3
1999 2
2000 1
2001 6
2002 5
2003 3
2004 3
2005 6
2006 5
2007 7
2008 3
2009 6
2010 3
2011 2
2012 7
2013 11
2014 8
2015 11
2016 7
2017 6
2018 6
2019 10
2020 15
2021 18
2022 13
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

167 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Graft-versus-host disease, susceptibility to"
Page 1
Acute Graft-Versus-Host Disease: A Brief Review.
Aladağ E, Kelkitli E, Göker H. Aladağ E, et al. Turk J Haematol. 2020 Feb 20;37(1):1-4. doi: 10.4274/tjh.galenos.2019.2019.0157. Epub 2019 Sep 2. Turk J Haematol. 2020. PMID: 31475512 Free PMC article. Review.
Graft-versus-host disease (GvHD) is an important complication that can be observed after allogeneic hematopoietic stem cell transplantation (allo-HSCT). ...
Graft-versus-host disease (GvHD) is an important complication that can be observed after allogeneic hemat …
Resolution of acute intestinal graft-versus-host disease.
Thiagarajan S, Neurath MF, Hildner K. Thiagarajan S, et al. Semin Immunopathol. 2019 Nov;41(6):655-664. doi: 10.1007/s00281-019-00769-w. Epub 2019 Oct 31. Semin Immunopathol. 2019. PMID: 31673757 Review.
Despite its lifesaving potential, immune-mediated allo-reactivity inherent to the allogeneic transplantation can be observed within up to 50% of all allo-HCT patients regularly resulting in the manifestation of acute and/or chronic graft-versus-host …
Despite its lifesaving potential, immune-mediated allo-reactivity inherent to the allogeneic transplantation can be observed within u …
GATA2 Deficiency: Predisposition to Myeloid Malignancy and Hematopoietic Cell Transplantation.
Rajput RV, Arnold DE. Rajput RV, et al. Curr Hematol Malig Rep. 2023 Aug;18(4):89-97. doi: 10.1007/s11899-023-00695-7. Epub 2023 May 29. Curr Hematol Malig Rep. 2023. PMID: 37247092 Review.
A recent report of 59 patients with GATA2 deficiency who underwent allogenic HCT with myeloablative, busulfan-based conditioning and post-transplant cyclophosphamide reported excellent overall and event-free survival of 85% and 82% with reversal of disease phenotype and lo …
A recent report of 59 patients with GATA2 deficiency who underwent allogenic HCT with myeloablative, busulfan-based conditioning and post-tr …
Fetal allotransplant recipients are resistant to graft-versus-host disease.
Riley JS, McClain LE, Stratigis JD, Coons BE, Bose SK, Dave A, White BM, Li H, Loukogeorgakis SP, Fachin CG, Dias AIBS, Flake AW, Peranteau WH. Riley JS, et al. Exp Hematol. 2023 Feb;118:31-39.e3. doi: 10.1016/j.exphem.2022.12.004. Epub 2022 Dec 17. Exp Hematol. 2023. PMID: 36535408 Free PMC article.
In utero hematopoietic cell transplantation (IUHCT) is an experimental treatment for congenital hemoglobinopathies, including Sickle cell disease and thalassemias. One of the principal advantages of IUHCT is the predisposition of the developing fetus toward immunologic tol …
In utero hematopoietic cell transplantation (IUHCT) is an experimental treatment for congenital hemoglobinopathies, including Sickle cell …
Vascular endothelium and graft-versus-host disease.
Biedermann BC. Biedermann BC. Best Pract Res Clin Haematol. 2008 Jun;21(2):129-38. doi: 10.1016/j.beha.2008.02.003. Best Pract Res Clin Haematol. 2008. PMID: 18503981 Review.
Vascular endothelial cells are an exposed target tissue for immune-mediated injury during graft-versus-host disease (GVHD). However, widespread endothelial death resulting in multi-organ failure similar to that in hyperacute solid-organ transplant reje …
Vascular endothelial cells are an exposed target tissue for immune-mediated injury during graft-versus-host disease …
Experimental Models of Infectious Pulmonary Complications Following Hematopoietic Cell Transplantation.
Zhou X, Moore BB. Zhou X, et al. Front Immunol. 2021 Aug 16;12:718603. doi: 10.3389/fimmu.2021.718603. eCollection 2021. Front Immunol. 2021. PMID: 34484223 Free PMC article. Review.
The prevalence and type of infection changes over time and is influenced by the course of immune reconstitution post-transplant. The interaction between pathogens and host immune responses is complex in HCT settings, since the conditioning regimens create periods of neutro …
The prevalence and type of infection changes over time and is influenced by the course of immune reconstitution post-transplant. The interac …
Antibody-mediated pathogenesis of chronic GVHD through DBY/HLA class II complexes and induction of a GVL effect.
Umino K, Morita K, Ikeda T, Kawaguchi SI, Nagayama T, Ito S, Minakata D, Ashizawa M, Yamamoto C, Hatano K, Sato K, Ohmine K, Fujiwara SI, Kimura SI, Kako S, Doki N, Ozawa Y, Mori Y, Eto T, Hiramoto N, Nakamae H, Kanda J, Ichinohe T, Atsuta Y, Nakasone H, Morishima S, Kanda Y. Umino K, et al. Blood. 2023 Sep 14;142(11):1008-1021. doi: 10.1182/blood.2023019799. Blood. 2023. PMID: 37363859
Chronic graft-versus-host disease (cGVHD) is a multiorgan syndrome with clinical features resembling those of autoimmune diseases. ...The presence of alloantibodies against DBY/HLA class II complexes significantly predicted the occurrence of cGV …
Chronic graft-versus-host disease (cGVHD) is a multiorgan syndrome with clinical features resembling those of au …
Intestinal transplantation: an overview of the recent experimental studies.
Oltean M. Oltean M. Curr Opin Organ Transplant. 2021 Apr 1;26(2):240-244. doi: 10.1097/MOT.0000000000000845. Curr Opin Organ Transplant. 2021. PMID: 33395113 Review.
RECENT FINDINGS: During the recent years, ischemia-reperfusion injury (IRI) and Graft-versus-host disease (GVHD) have gradually replaced acute rejection as the main research topic. ...A new experimental model of modified multivisceral transplantation i …
RECENT FINDINGS: During the recent years, ischemia-reperfusion injury (IRI) and Graft-versus-host disease (GVHD) …
Baseline predictors influencing the prognosis of invasive aspergillosis in adults.
Koehler P, Salmanton-García J, Gräfe SK, Koehler FC, Mellinghoff SC, Seidel D, Steinbach A, Cornely OA. Koehler P, et al. Mycoses. 2019 Aug;62(8):651-658. doi: 10.1111/myc.12926. Epub 2019 May 23. Mycoses. 2019. PMID: 31066092 Review.
Regarding state of immunosuppression, negative outcome predictors were prolonged neutropenia (12.5%, 17/136), corticosteroid treatment (8.1%, 11/136) and graft-vs-host disease (3.7%, 5/136). ...IA-specific predictors were disseminated …
Regarding state of immunosuppression, negative outcome predictors were prolonged neutropenia (12.5%, 17/136), corticosteroid treatmen …
Management of PTLD After Hematopoietic Stem Cell Transplantation: Immunological Perspectives.
Compagno F, Basso S, Panigari A, Bagnarino J, Stoppini L, Maiello A, Mina T, Zelini P, Perotti C, Baldanti F, Zecca M, Comoli P. Compagno F, et al. Front Immunol. 2020 Sep 16;11:567020. doi: 10.3389/fimmu.2020.567020. eCollection 2020. Front Immunol. 2020. PMID: 33042147 Free PMC article. Review.
Although considered rare events, PTLDs have been increasingly observed with the widening application of HSCT from alternative sources, including cord blood and HLA-haploidentical stem cell grafts, and the use of novel agents for the prevention and treatment of rejection an …
Although considered rare events, PTLDs have been increasingly observed with the widening application of HSCT from alternative sources …
167 results